Precigen, Inc. EV/EBIT

EV/EBIT of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBIT growth rates and interactive chart. EV/EBIT is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes (EBIT), but after Depreciation and Amortization.. The EV/EBIT ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBIT compared to a stock’s historical average or industry can indicate undervaluation. EV/EBIT takes into account the reinvestment needs of a business (depreciation, amortization).

Highlights and Quick Summary

Current EV/EBIT of Precigen, Inc. is 0.0 (as of December 31, 2022)
  • EV/EBIT for the quarter ending March 31, 2023 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBIT decreased by NaN%
  • Annual EV/EBIT for 2022 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBIT for 2021 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBIT for 2020 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBIT of Precigen, Inc.

Most recent EV/EBITof PGEN including historical data for past 10 years.

Interactive Chart of EV/EBIT of Precigen, Inc.

Precigen, Inc. EV/EBIT for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.0 – – – –
2022 0.0 0.0 0.0 0.0 0.0
2021 0.0 0.0 0.0 0.0 0.0
2020 0.0 0.0 0.0 0.0 0.0
2019 0.0 0.0 0.0 0.0 0.0
2018 0.0 0.0 0.0 0.0 0.0
2017 0.0 0.0 0.0 0.0 0.0
2016 0.0 0.0 0.0 0.0 0.0
2015 0.0 0.0 0.0 0.0 0.0
2014 0.0 0.0 0.0 0.0 0.0
2013 0.0 0.0 0.0 0.0 0.0
2012 0.0 0.0 – – 0.0

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com